Drug Overview
Welcome to our comprehensive patient and clinical guide. Bausch & Lomb Advanced Eye Relief Dry Eye Rejuvenation Lubricant Eye Drops serve as a primary defense against the discomfort of chronic ocular surface disease. Classified under the Ophthalmology category, this medication belongs to the LUBRICANT drug class, commonly referred to as artificial tears.
- Generic Name: Glycerin (0.3%) and Propylene Glycol (1.0%)
- US Brand Names: Bausch & Lomb Advanced Eye Relief Dry Eye Rejuvenation
- Route of Administration: Topical Drops
- FDA Approval Status: FDA-approved (Over-the-Counter Monograph)
What Is It and How Does It Work? (Mechanism of Action)

This medication is a dual-action LUBRICANT that restores the natural environment of the eye. The active ingredients, glycerin and propylene glycol, are demulcents and humectants. At the physiological level, they bind to water molecules, preventing the rapid evaporation of the aqueous layer of the tear film.
Dry eyes cause tears to become highly concentrated with salt (hyperosmolarity), damaging surface cells and triggering inflammation. By drawing moisture back into epithelial cells, glycerin acts as a TARGETED THERAPY to reduce tear osmolarity. Propylene glycol creates a protective shield over the cornea, lowering friction during blinking and protecting goblet cells, which produce natural mucus to anchor the tear film.
FDA-Approved Clinical Indications
This medication is officially recognized for specific ocular needs.
- Primary Indication: Relief of chronic dry eye symptoms.
- Other Approved & Off-Label Uses:
- Computer Vision Syndrome: Relieving dryness caused by reduced blinking during prolonged digital screen use.
- Post-Surgical Dryness: Off-label management of mild dry eye following procedures like LASIK or cataract surgery to stabilize the ocular surface.
- Environmental Exposure: Protecting eyes from wind, sun, and dry indoor heating or air conditioning.
By maintaining a stable tear film, this LUBRICANT prevents microscopic corneal scratches and supports clear, uninterrupted visual acuity throughout the day, preserving the integrity of the ocular surface.
Dosage and Administration Protocols
Proper application is essential for maximizing relief and preventing contamination.
| Indication | Standard Dose | Frequency |
| Relief of chronic dry eye symptoms | 1 to 2 drops in the affected eye(s) | As needed to relieve symptoms |
| Computer Vision Syndrome (Off-Label) | 1 drop in the affected eye(s) | Prior to screen use, then every 2 to 4 hours |
| Post-Surgical Dryness (Off-Label) | 1 drop in the affected eye(s) | 2 to 4 times daily, as directed |
Dose Adjustments and Special Populations:
- Pediatric Use: Generally safe for children, but consult a pediatrician or eye care specialist before use.
- Contact Lens Wearers: This formula contains preservatives. Soft contact lenses should be removed prior to instillation and left out for at least 15 minutes to avoid lens damage.
Dosage must be individualized by a qualified healthcare professional.
Clinical Efficacy and Research Results
Extensive clinical observations (2020-2026) confirm that dual-action lubricants significantly improve the quality of life for patients with dry eye.
Research data indicates that regular use increases Tear Film Break-Up Time (TBUT) by an average of 3.5 to 5.0 seconds, meaning the tears stay intact on the eye much longer before evaporating. Furthermore, patients report an average 15-point reduction on the Ocular Surface Disease Index (OSDI) questionnaire, demonstrating a sharp decrease in daily pain, gritty sensations, and light sensitivity.
By maintaining a consistent moisture barrier, this drop is highly efficacious in preventing the cycle of inflammation and tissue damage that can eventually lead to scarring or blurred vision, helping patients maintain optimal Best Corrected Visual Acuity (BCVA) over time.
Safety Profile and Side Effects
Black Box Warning: There is no Black Box Warning for this over-the-counter medication.
While generally very safe, all treatments carry some risks.
Common Side Effects (>10%)
- Mild, temporary stinging or burning immediately upon instillation.
- Briefly blurred vision as the thick drop spreads across the cornea.
Serious Adverse Events
- Allergic Contact Dermatitis: Swelling or redness of the eyelids, often a reaction to the preservative Benzalkonium Chloride (BAK).
- Corneal Toxicity: With excessive use (more than 4 to 6 times a day), BAK can cause corneal surface damage or “melting” over a long period.
Management Strategies
Ensure sterile administration by never touching the dropper tip to your eye, fingers, or any surface. If you experience sudden pain, worsening redness, or persistent “floaters,” stop use immediately and consult your eye doctor to minimize unwanted systemic or ocular exposure.
Research Areas
Direct Clinical Connections
Ophthalmic research (2020-2026) focuses on how hyperosmolar lubricants interact with retinal pigment epithelium (RPE) health indirectly by reducing anterior segment inflammation. Researchers are studying how humectant combinations protect goblet cell density, helping the eye produce high-quality tears naturally.
Severe Disease & Surgical Integration
While these drops manage mild to moderate symptoms, scientists are exploring their role in severe conditions. Research evaluates how pre-treating the eyes with high-viscosity lubricants can improve the accuracy of preoperative measurements for cataract surgeries and act as a supportive therapy to prevent blindness in end-stage glaucoma by keeping the cornea clear during harsh intraocular pressure treatments.
Disclaimer: These studies regarding advanced surgical integration and RPE interactions are currently in the preclinical phase and are not yet applicable to practical or professional clinical scenarios.
Patient Management and Clinical Protocols
Pre-treatment Assessment
Initial evaluations include:
- Baseline Diagnostics: Visual Acuity, Tonometry (IOP measurement), and Slit-lamp examinations to assess corneal damage.
- Ocular Imaging: Optical Coherence Tomography (OCT) to measure the tear meniscus.
- Specialized Testing: Tear film break-up time (TBUT) and Schirmer’s test to measure natural tear volume.
- Screening: Checking for a history of ocular surgeries, allergies to preservatives like BAK, or underlying autoimmune conditions.
Monitoring and Precautions
- Vigilance: Monitor for rebound redness indicating preservative toxicity.
- Lifestyle: UV protection (sunglasses), daily eyelid hygiene (lid scrubs), and frequent screen breaks using the 20-20-20 rule.
- Do’s and Don’ts:
- DO: Wash your hands thoroughly before applying drops.
- DO: Wait 5 minutes between different types of eye drops.
- DON’T: Use this medication while wearing soft contact lenses unless instructed.
- DON’T: Share your eye drops with anyone else.
Legal Disclaimer
The information provided in this guide is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider regarding any medical condition or treatment plan.